This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Recursion Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Chris Radoux: Innovator in MALT-1 Modulation
Introduction
Chris Radoux is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biomedical research, particularly in the modulation of MALT-1. His work focuses on developing innovative compounds and methods for treating various diseases and conditions.
Latest Patents
Chris Radoux holds a patent for MALT-1 modulators. This patent discloses compounds, compositions, and methods for treating diseases, syndromes, conditions, and disorders that are influenced by the modulation of MALT-1. The compounds are represented by specific formulas, wherein the variables are defined in the patent documentation. He has 1 patent to his name.
Career Highlights
Chris is currently employed at Recursion Pharmaceuticals, Inc., where he continues to advance his research in the field. His work is pivotal in developing therapeutic solutions that can significantly impact patient care and treatment outcomes.
Collaborations
Throughout his career, Chris has collaborated with esteemed colleagues, including Peter Ray and David Evans. These partnerships have fostered a collaborative environment that enhances innovation and research productivity.
Conclusion
Chris Radoux is a dedicated inventor whose work in MALT-1 modulation holds promise for advancing medical treatments. His contributions to the field exemplify the importance of innovation in addressing complex health challenges.